Methylphenidate
- Generic Name
- Methylphenidate
- Brand Names
- Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO2
- CAS Number
- 113-45-1
- Unique Ingredient Identifier
- 207ZZ9QZ49
- Background
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve ...
- Indication
Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy
- Associated Therapies
- -
Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3
- Conditions
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 20
- Registration Number
- NCT00015054
- Locations
- 🇺🇸
Cincinnati MDRU, Cincinnati, Ohio, United States
Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5
- Conditions
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015223
- Locations
- 🇺🇸
Cincinnati MDRU, Cincinnati, Ohio, United States
Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11
- Conditions
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015301
- Locations
- 🇺🇸
New York MDRU, New York, New York, United States
Treatment of Youth With ADHD and Anxiety
- Conditions
- First Posted Date
- 2001-03-16
- Last Posted Date
- 2009-06-24
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 120
- Registration Number
- NCT00012584
- Locations
- 🇺🇸
UCLA Neuropsychiatric Institute, Los Angeles, California, United States
🇺🇸New York State Psychiatric Institute, New York, New York, United States
🇺🇸New York University Child Study Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.